Outcomes after transplant in relapsed/refractory KMT2Ar (MLLr) and mNPM1 (NPM1c) leukemia patients achieving remissions after menin inhibition: SNDX-5613 (revumenib) Ph1 experience Meeting Abstract
| Authors: | Issa, G. C.; Cuglievan, B.; Stein, E.; Arellano, M. L.; Žucenka, A.; Khera, N.; Stone, R. M.; Thirman, M. J.; DiPersio, J. F.; Karras, N.; Gu, Y.; Bagley, R. G.; Rosen, G.; Tamang, D.; Dishman, K.; Scalera, S.; Meyers, M. L.; Madigan, K.; McNeer, N.; Aldoss, I. |
| Abstract Title: | Outcomes after transplant in relapsed/refractory KMT2Ar (MLLr) and mNPM1 (NPM1c) leukemia patients achieving remissions after menin inhibition: SNDX-5613 (revumenib) Ph1 experience |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 914 |
| End Page: | 916 |
| Language: | English |
| ACCESSION: | WOS:000893223200376 |
| DOI: | 10.1182/blood-2022-164600 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
